In­cyte ax­es blood can­cer col­lab with Sy­ros

In­cyte de­cid­ed not to ad­vance its blood can­cer col­lab­o­ra­tion with Sy­ros Phar­ma­ceu­ti­cals in an­oth­er blow to the biotech’s part­ner­ship port­fo­lio.

In­cyte gave

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER